Ghaleb Husseini graduated with Bachelor of Science and Master of Science degrees in 1995 and 1997, respectively, from Brigham Young University, where he also finished his doctoral research in chemical engineering with an emphasis in biomedical engineering in 2001. In January 2004, he was appointed as an assistant professor in chemical engineering at AUS, where he was promoted to associate professor and professor in 2008 and 2013, respectively. He served as the Associate Dean of Graduate Studies and Research in the AUS College of Engineering for two years starting May 2017. He works in the area of ultrasonic drug delivery. He has 200 academic publications, two patents (2 more filed) and five book chapters, and is cited over 4900 times. According to Google Scholar, he holds an h-index & i10-index of 36 and 68, respectively. He secured funding from the Patient’s Friends Committee-Sharjah, AlJalila Foundation, Al Qasimi Foundation, the Technology Innovation Pioneer-Healthcare (TIP) Program, Takamul, Sheikh Hamdan Award for Medical Sciences, Friends of Cancer Patients, the Ameera Fund and the Dana Gas Endowed Chair for Chemical Engineering. Dr. Husseini held the distinguished lecturer position at IEEE-EMBS (Institute of Electrical and Electronics Engineers - Engineering in Medicine and Biology Society) Jan 2014- Dec 2015. His project entitled "Nanocarriers and Ultrasound in Cancer Treatment" was highly commended as the Institute of Chemical Engineers (ICHEME) Research Project of the Year - ICHEME Global Awards 2016, and was shortlisted again in the Pharma Category in the ICHEME Global Awards 2018. In May 2018, he won the TIP (Technology Innovation Pioneer) Health Care Award. Ghaleb has been appointed as an Associate Editor for IEEE Transactions on Nanobioscience May 2020. He is also serving on the editorial board of the International Review of Applied Sciences and Engineering (IRASE) and served on the editorial board of the European Journal of Nanomedicine 2016-2018. Dr. Husseini spent a sabbatical at the École Polytechnique Fédérale de Lausanne (EPFL), Switzerland, working in Dr. Jeffrey A. Hubbell's laboratory and is currently serving as the Dana Gas Endowed Chair for Chemical Engineering.
Most research interests for a scientist
Ghaleb works in the area of ultrasonic drug delivery. His research focuses on investigating novel drug delivery systems to reduce the side effects of chemotherapy by encapsulating the chemotherapeutic agent in a nano-sized carrier until it reaches the tumor site. These carriers include solid nanoparticles, micelles, liposomes and e-liposomes. Once the nanoparticle reaches the desired location, ultrasound is applied to release the chemotherapy drug directly to the cancer site, thus avoiding any interaction with the healthy cells in the body. This minimizes the adverse side effects of chemotherapy.
- Nanotechnology in Cancer Treatment